- Home
- NRIM vs BME Comparison
NRIM vs BME Comparison
Compare NRIM & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRIM
- BME
- Stock Information
- Founded
- NRIM 1990
- BME 2005
- Country
- NRIM United States
- BME United States
- Employees
- NRIM N/A
- BME N/A
- Industry
- NRIM Savings Institutions
- BME Trusts Except Educational Religious and Charitable
- Sector
- NRIM Finance
- BME Finance
- Exchange
- NRIM Nasdaq
- BME Nasdaq
- Market Cap
- NRIM 500.9M
- BME 462.3M
- IPO Year
- NRIM N/A
- BME N/A
- Fundamental
- Price
- NRIM $86.62
- BME $35.51
- Analyst Decision
- NRIM
- BME
- Analyst Count
- NRIM 0
- BME 0
- Target Price
- NRIM N/A
- BME N/A
- AVG Volume (30 Days)
- NRIM 78.8K
- BME 34.0K
- Earning Date
- NRIM 07-23-2025
- BME 01-01-0001
- Dividend Yield
- NRIM 2.96%
- BME 6.26%
- EPS Growth
- NRIM 46.48
- BME N/A
- EPS
- NRIM 7.52
- BME 1.44
- Revenue
- NRIM $164,695,000.00
- BME N/A
- Revenue This Year
- NRIM N/A
- BME N/A
- Revenue Next Year
- NRIM $7.05
- BME N/A
- P/E Ratio
- NRIM $11.52
- BME $28.37
- Revenue Growth
- NRIM 26.35
- BME N/A
- 52 Week Low
- NRIM $54.58
- BME $35.53
- 52 Week High
- NRIM $92.45
- BME $43.20
- Technical
- Relative Strength Index (RSI)
- NRIM 47.24
- BME 39.79
- Support Level
- NRIM $86.00
- BME $35.60
- Resistance Level
- NRIM $88.23
- BME $36.71
- Average True Range (ATR)
- NRIM 1.99
- BME 0.36
- MACD
- NRIM -0.80
- BME -0.04
- Stochastic Oscillator
- NRIM 10.80
- BME 6.25
About NRIM Northrim BanCorp Inc
Northrim BanCorp Inc is a bank holding company. The Company operates in three reportable segments: Community Banking, Home Mortgage Lending, and Specialty Finance. It generates maximum revenue from the Community Banking segment which offers loan and deposit products to business and consumer customers in its market areas and operates nearly 20 branches throughout Alaska.
About BME Blackrock Health Sciences Trust
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.